National Bank of Canada
SRPT icon

National Bank of Canada’s Sarepta Therapeutics SRPT Stock Holding History

National Bank of Canada’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9K Buy
1,106
+113
+11% +$2.14K ﹤0.01% 2247
2026
Q1 		$21.5K Sell
993
-222,891
-100% -$4.31M ﹤0.01% 2158
2025
Q4 		$4.82M Buy
223,884
+223,644
+93,185% +$4.71M ﹤0.01% 875
2025
Q3 		$4.62K Buy
240
+142
+145% +$2.53K ﹤0.01% 2465
2025
Q2 		$1.67K Sell
98
-312
-76% -$13.3K ﹤0.01% 2637
2025
Q1 		$26.2K Sell
410
-5
-1% -$526 ﹤0.01% 2030
2024
Q4 		$50.5K Buy
415
+28
+7% +$3.43K ﹤0.01% 1950
2024
Q3 		$48.3K Sell
387
-7,140
-95% -$987K ﹤0.01% 1717
2024
Q2 		$1.18M Buy
7,527
+369
+5% +$47.4K ﹤0.01% 1031
2024
Q1 		$944K Sell
7,158
-4,835
-40% -$592K ﹤0.01% 1144
2023
Q4 		$1.15M Buy
11,993
+4,500
+60% +$432K ﹤0.01% 1108
2023
Q3 		$889K Sell
7,493
-12,156
-62% -$1.37M ﹤0.01% 1235
2023
Q2 		$2.23M Buy
19,649
+10,526
+115% +$1.36M ﹤0.01% 967
2023
Q1 		$1.26M Sell
9,123
-291,357
-97% -$37.8M ﹤0.01% 978
2022
Q4 		$38.9M Buy
300,480
+300,322
+190,077% +$34.8M 0.1% 179
2022
Q3 		$17K Hold
158
– – ﹤0.01% 2062
2022
Q2 		$12K Hold
158
– – ﹤0.01% 2222
2022
Q1 		$12K Hold
158
– – ﹤0.01% 2327
2021
Q4 		$14K Buy
+158
New +$13.5K ﹤0.01% 2259

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

National Bank of Canada's SRPT Position: Q2 2026 in Review

National Bank of Canada increased its Sarepta Therapeutics (SRPT) stake by 11% in Q2 2026, buying an estimated $2.14K and bringing the position to 1,106 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

National Bank of Canada first reported a position in SRPT in Q4 2021 and has held it in 19 quarters since. The position peaked at $38.9M in Q4 2022. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • National Bank of Canada held 1,106 shares of Sarepta Therapeutics worth $19.9K as of Q2 2026.
  • National Bank of Canada bought 113 Sarepta Therapeutics shares in Q2 2026, an estimated $2.14K.
  • Sarepta Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2247 holding.
  • National Bank of Canada first reported a position in Sarepta Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Sarepta Therapeutics position peaked at $38.9M in Q4 2022.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.